Ionis Pharmaceuticals
IONS
IONS
316 hedge funds and large institutions have $5.72B invested in Ionis Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 89 increasing their positions, 115 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
316
Holders Change
+15
Holders Change %
+4.98%
% of All Funds
7.18%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.11%
New
55
Increased
89
Reduced
115
Closed
38
Calls
$60.9M
Puts
$73.5M
Net Calls
-$12.6M
Net Calls Change
+$1.97M
Top Buyers
| 1 |
BC
Boxer Capital
San Diego,
California
|
+$22.6M |
| 2 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$13.8M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$13.3M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$12.3M |
| 5 |
Goldman Sachs
New York
|
+$12.2M |
Top Sellers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$58.8M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$29.2M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$26.1M |
| 4 |
ClearBridge Investments
New York
|
-$22.9M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$17.9M |
